Maynard Um
-
-
-
-
-
-
-
Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
-
-
-
-
-
-
-
Compass Therapeutics (CMPX) PT Raised to $7 at Leerink Partners
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)
-
-
-
-
-
-
-
Piper Sandler Starts Compass Therapeutics (CMPX) at Overweight
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

